Bellevue Life Sciences Acquisition Corp. 8-K Filing: Key Securities Offerings Insights

Based on the provided section of the financial report, here are the key insights:

1. Entity Identification:

• The entity is Bellevue Life Sciences Acquisition Corp. with SEC CIK number 0001840425.

2. Filing Type and Date:

• This is an 8-K filing indicating it is a current report used to disclose major events that shareholders should know about.
• The filing date is February 13, 2025.

3. Securities Offered:

• The report outlines units being offered, each consisting of:
• • One share of common stock
  • One redeemable warrant
  • One right
• The common stock has a par value of $0.0001 per share.

4. Warrant Details:

• The redeemable warrants are exercisable for shares of common stock at an exercise price of $11.50 per share.

5. Right to Receive:

• Each unit includes a right to receive one-tenth (1/10) of one share of common stock.

6. Stock Tickers:

• The relevant stock tickers for these securities are:
• • BLACU for the units
  • BLAC for common stock
  • BLACW for redeemable warrants
  • BLACR for rights

7. Location and Contact Information:

• The company is located at 10900 NE 4th Street, Suite 2300, Bellevue, WA 98004 with a contact number of 425-635-7700.

8. Units and Measures:

• The report uses multiple units of measurement including USD for currency and shares for equity.

This information provides a snapshot of the company's current financial activity concerning securities offerings and outlines the structure of the units being offered, which may be of interest to potential investors and analysts.